What is Pfizer's net worth? Pfizer's net worth is $67.425 billion. Pfizer began as a joint venture between two German-American relatives, Charles Pfizer and Charles Erhart. The two men, cousins, launched a lab and business in Williamsburg, Brooklyn in the mid-1840s, in which they produced santonin, an antiparasitic. They then expanded into producing citric acid, and suddenly, they were off and running. They expanded their facilities multiple times over the course of the next fifty years, and by the turn of the century, the company was making a multi-million dollar profit. Their production of penicillin during World War II, based on their own fermentation process, cemented them as the most widely used pharmaceutical company. In the 1950s, Pfizer shifted its focus to research and development and has remained focused on these goals since. They have developed such drugs as Terramycin (antibiotic) Feldene (anti-inflammatory), Zoloft (antidepressant), Lipitor (lowers cholesterol), Diflucan (antifungal), and Viagra (erectile dysfunction), among many others. The company now distributes pharmaceuticals around the world, and various Pfizer products can be found in Belgium, Brazil, the UK, Canada, Iran, and Mexico, among a large number of other countries. The company currently employs 103,700 people, and still carried out a portion of research at its Brooklyn lab until 2005. The administrative offices are in Manhattan, and the primary lab has been located in Groton, Connecticut since 1960.
Pfizer, Inc. is an American multinational pharmaceutical corporation headquartered in New York City, and with its research headquarters in Groton, Connecticut, United States. It is one of the world's largest pharmaceutical companies by revenues. Pfizer develops and produces ...
- Pfizer Inc.
- PFIZER INC
Pfizer and Merck Receive Key Regulatory ApprovalsShares of Pfizer and Merck are in the spotlight on Wednesday after both companies won some key federal regulatory approvals. Pfizer received the ba...
Becker Fund Manager: 'Howard Hughes and Pfizer Will Head Higher'Pfizer's stock may currently be out of favor, but the drug giant's fortunes will soon turn due to its strong cash flow and undervalued pipeline, sa...
Generics Eat into Pfizer's SalesPfizer's quarterly revenue fell as generic competition over blockbuster drugs like Viagra cut into sales.
Lex V Lombard On Pfizer/AstraZeneca - YouTubeRobert Armstrong, head of Lex, and Jonathan Guthrie, Lombard editor, go head- to-head to ...